Dibotatug

N/A

Report date: 2025/05/20 15:34:35

Base Information

Drug NameDibotatug
Drug Alias NameDR-01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti-CD94
TargetsNatural killer cells antigen CD94
Therapy Area/IndicationsVitiligoAlopecia AreataAutoimmune Diseases of the Nervous System +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanNew Zealand +[10] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDren Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesDren Bio Inc
Inactive CompaniesN/A
Active IndicationsVitiligoAlopecia AreataAutoimmune Diseases of the Nervous System +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A